Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 20Recruiting 11Terminated 6Unknown 4Withdrawn 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 2Lymphoid 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Lymphoma, Follicular 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × fluciclovine F-18 × Clear all
NCT03762759 2024-05-17

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Emory University

Phase 2 Unknown
140 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT05479136 2022-10-27

DRARCH

St. Joseph's Hospital and Medical Center, Phoenix

Phase 3 Unknown
30 enrolled
Lymphoid

Lymphoma, Follicular

NCT03349463 2020-02-28

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.

Loyola University

Phase 4 Unknown
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03996993 2019-06-25

Defining Recurrent Disease With Axuminâ„¢

Cancer Center of Irvine

Unknown
20 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡